Evaluation of a community pharmacist-led minor ailments service in collaboration with general practitioners: a cluster randomised controlled trial

Not Applicable

Completed

• Conditions: Gastroesophageal reflux; Cough; Common cold; Primary dysmenorrhoea; Tension headache; Migraine; Non specific low back pain; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Respiratory - Other respiratory disorders / diseases; Infection - Other infectious diseases

• Registration Number: ACTRN12618000286246
• Lead Sponsor: niversity of Technology Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-23
• Study Completion: 2019-04-14
• Last Update Posted: 10 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 894

Inclusion Criteria

Consumers aged 18 or over will be identified due to one of the qualifying criteria which include:
–– Presenting to the pharmacy in person;
–– Requesting either purchase of a Pharmacy Medicine, the purchase of a Pharmacist Only Medicine, or treatment for symptoms for one of the following ailments (reflux, cough, common cold, headache (tension or migraine), primary dysmenorrhoea and low back pain);
–– Ability to provide written informed consent to participate in the study;
–– Accessible by telephone.

Exclusion Criteria

No exclusion criteria will be applied.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Appropriate use of non-prescription medicines - defined as the use of medication as meeting the entire requirement as approved in product information (PI) by the Therapeutic Goods Administation (TGA) e.g. indications of use, dosage and contraindications. <br><br>The information will be collected by the pharmacist during a consultation. An independent researcher will assess the appropriateness of the medicine supplied to the consumer based on the TGA approved indications. [Baseline (index consultation pharmacist-patient). ];Appropriate medical referral rate - defined as meeting the agreed referral criteria in the respective treatment protocols (HealthPathways). <br><br>The information will be collected by the pharmacist during a consultation. An independent researcher will assess the appropriateness of referral based on the agreed referral criteria in HealthPathways. [Baseline (index consultation pharmacist-patient). ]